Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses.

导出 OA

翻译打印收藏纠错

作者： Amy,Chang ^[1] ; Teresa Py,Chiang ^[1] ; Jake D,Kim ^[1] ; Jonathan,Mitchell ^[1] ; Jennifer L,Alejo ^[1] ; Alexa A,Jefferis ^[1] ; Robin K,Avery ^[2] ; Aaron A R,Tobian ^[3] ; Macey L,Levan ^[4] ; Daniel S,Warren ^[1] ; Jacqueline M,Garonzik-Wang ^[5] ; Allan B,Massie ^[4] ; Dorry L,Segev ^[4] ; William A,Werbel ^[2]

作者单位： Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. ^[1] Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. ^[2] Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. ^[3] Department of Surgery, New York University Grossman School of Medicine, New York, New York, USA. ^[4] Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. ^[5]

主题词抗体, 病毒(Antibodies, Viral);人类(Humans);流感疫苗(Influenza Vaccines);器官移植(Organ Transplantation)

DOI 10.1111/ctr.14738

PMID 35670813

发布时间 2022-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交